Liu W, Kelly JW, Trivett M, Murray WK, Dowling JP, Wolfe R, Mason G, Magee J, Angel C, Dobrovic A, McArthur GA
Julia Moore Vogel, senior program director at the Scripps Research Translational Institute, noted that LoCITT enables even patients with the most severe symptoms to join the search for answers. Vogel, who has long COVID, and Eric Topol are co-principal investigators of the study
The cardiovascular benefits of GLP-1s and GIPs may be independent of improvements in glycemic control, and in part be driven by reduction in inflammation, a key driver of arterial plaque formation
Anti-aging and cellular damage repair slows down free radical damage and protects brain function
Although not previously reported, we also observed increases of lysine, dimethyl-arginine, and N-acetyl-(iso)leucine (Fig